Since 1989, at ferropharma we are changing the health care market by cutting value chains to decrease cost of drug development and drug availability. One of our brands, EMELEMA® - Making Latest Medicine Available - is what we believe in and what drives the best talent from around the globe to join us.
Our aim is to be known as the company that increases patient access to generic and innovative medicine. We focus on building bridges between markets, stakeholders and patients. Collectively, we believe in finding the most fair, straight and reliable provider for the distribution of Biotechnologies, Finished Dosage Forms (FDF), medical devices, and services. Thanks to our dedicated teams in Brazil, Singapore, India, United Kingdom, Germany, and Malta, we are using manufacturing plants for high quality products, in the most efficient way. We direct our attention on novel delivery systems and the provision of EU registered and manufactured drugs.
We made quality our priority. The EMA, FDA and ANVISA standards for FDFs are our benchmarks that we fulfill. We operate worldwide but our core markets are China, Latin America and the European Union.
Especially for Bio Technology and drug development we focus on the most advanced and innovative regions around the world.
Founding of ferropharma as "Ferro Im- und Export GmbH"
Takeover by CARELA HOLDING GmbH and strategic repositioning
Start of transformation into an integrated (bio) pharma and service company
Integration of Brazilian sales activities into the group
Relaunch of new product portfolio and start of digitalization of all processes
Founding of Ferro Pharma Europe Ltd. in Malta
Hiring and onboarding of talent excellence in all levels in all locations
Investment into EsoCap AG, Switzerland
Founding of Ferro Pharma do Brasil Ltda. and of BioBrasil Importacao Ltda.
Founding of Ferro Pharma Asia Ltd. in Singapore
Registration in Malta as fully established pharmaceutical company for medicine
Launch of first FDF (chemically based injectables) from Malta into various LATAM markets
Launch of first biotechnology supplies to customers in Europe, USA, Asia and Brazil
Filing of first drugs via our local partner Sanval Ltda in Brasil, as partner of our own brand BioBrasil®.
Founding of EMELEMA GmbH.
Founding of Ferro Pharma UK Ltd.
Bao Pharma and ferropharma bio start mutual roll-out of Hyaluronidase at Bio Europe 2023
ferropharma bio is at the forefront of advancing innovative pharmaceuticals and BioSimilars through our groundbreaking hyaluronidase technology.
Single-Use technology gives you complete design flexibility in process development.